Intramyocellular lipids: Maker vs. marker of insulin resistance

Medical Hypotheses

Volumn 70, Issue 3, 2008, Pages 625-629

  Guo, ZengKui ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; TRIACYLGLYCEROL;

ARTICLE; FATTY ACID OXIDATION; GLUCOSE UTILIZATION; HUMAN; HYDROLYSIS; INSULIN RESISTANCE; MUSCLE METABOLISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; HUMANS; INSULIN; INSULIN RESISTANCE; KINETICS; MODELS, ANIMAL; MUSCLE CELLS; MUSCLE, SKELETAL; OXIDATION-REDUCTION; RATS; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 38849194111     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.03.044     Document Type: Article

References (41)

1. Storlien L.H., Jenkins A.B., Chrisholm D.J., Pascoe W.S., Khouri S., and Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rat. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40 (1991) 280-289
2. Pan D.A., Lillioja S., Kriketos A.D., Milner M.R., Baur L.A., Bogardus C., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46 (1997) 983-988
3. Kelley D.E., and Goodpaster B.H. Skeletal muscle triglyceride an aspect of regional adiposity and insulin resistance. Diabetes Care 24 (2001) 933-941
4. Guo Z.K., and Zhou L. Evidence for increased and insulin-resistant lipolysis in skeletal muscle of high-fat-fed rats. Metabolism 53 (2004) 794-798
5. Perseghin G., Scifo P., De Cobelli F., Pagliato E., Battezzati A., Arcelloni C., et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48 (1999) 1600-1606
6. Koyama K., Chen G., Lee Y., and Unger R.H. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 273 (1997) E708-E713
7. Russull J.C., Shillabeer G., Bar-Tana J., Lau D.C.W., Richardson M., Wenzel L.M., et al. Development of insulin resistance in the JCR:LA-Cp rat: role of triacylglycerol and effects of medica 16. Diabetes 47 (1998) 770-778
8. Szczepaniak L., Babcock E.E., Schick F., Bobbins R.L., Garg A., Burns D., et al. Measurement of intracellular triglyceride stores by 1H spectroscopy: validation in vivo. Am J Physiol 276 (1999) E977-E989
9. Jacob S., Machann J., Rett K., Brechtel K., Volk A., Renn W., et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offersprings of type 2 diabetic subjects. Diabetes 48 (1999) 1113-1119
10. Boesch C., Slotboom J., Hoppeler H., and Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37 (1997) 484-493
11. Sinha R., Dufour S., Petersen K.F., Lebon V., Enokeson S., Ma Y.Z., et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in Lean and Obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51 (2002) 1022-1027
12. Schick F., Eismann B., Jung W.I., Bongers H., Bunse M., and Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29 (1993) 158-167
13. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Sig 12 (2000) 583-594
14. Ye J.M., Doyle P.J., Iglesias M.A., Watson D.G., Cooney G.J., and Kraegen E.W. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 50 (2001) 411-417
15. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277 (2002) 50230-50236
16. Sacchetti M., Saltin B., Olsen D.B., and van Hall G. High triacylglycerol turnover rate in human skeletal muscle. J Physiol 561 (2004) 883-891
17. Guo Z.K., Burguera B., and Jensen M.D. Kinetics of intramuscular triglyceride fatty acids in exercising humans. J Appl Physiol 89 (2000) 2057-2064
18. Guo Z.K., and Zhou L. Muscle type-dependent responses to insulin in intramyocellular triglyceride turnover in obese rats. Obes Res 13 (2005) 2081-2087
19. Corcoran M.P., Lamon-Fava S., and Fielding R.A. Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am J Clin Nutr 85 (2007) 662-677
20. Lee W.N., Lim S., Bassilian S., Bergner E.A., and Edmond J. Fatty acid cycling in human hepatoma cells and the effects of troglitazone. J Biol Chem 273 (1998) 20929-20934
21. Pande S.V. Carnitine-acylcarnitine translocase deficiency. Am J Med Sci 318 (1999) 22-27
22. Ogata T., and Yamasaki Y. Scanning electron-microscopic studies on the three-dimensional structure of mitochondria in the mammalian red, white and intermediate muscle fibers. Cell Tissue Res 241 (1985) 251-256
23. Randle P.J., Garland P.B., and Hales C.N. The glucose-fatty acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
24. Elks M.L. Fat oxidation and diabetes of obesity: the randle hypothesis revisited. Med Hyp 33 (1990) 257-260
25. Finck B.N., Bernal-Mizrachi C., Han D.H., Coleman T., Sambandam N., LaRiviere L.L., et al. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. Cell Metab 1 (2005) 133-144
26. Groop L.C., Bonadonna R.C., Shank M., Petrides A.S., and DeFronzo R.A. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest 87 (1991) 83-89
27. Zorzano A., Balon T.W., Brady L.J., Rivera P., Garetto L.P., Young J.C., et al. Effects of starvation and exercise on concentrations of citrate, hexose phosphates and glycogen in skeletal muscle and heart evidence for selective operation of the glucose-fatty acid cycle. Biochem J 232 (1985) 585-591
28. Jeukendrup A.E. Regulation of fat metabolism in skeletal muscle. Ann N Y Acad Sci 967 (2002) 217-235
29. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 106 (2000) 171-176
30. Lykidis A., Mougios V., and Arzoglou P. Kinetics of the two-step hydrolysis of triacylglycerol by pancreatic lipases. Eur J Biochem 230 (1995) 892-898
31. Peluso G., Petillo O., Margarucci S., Mingrone G., Greco A.V., Indiveri C., et al. Decreased mitochondrial carnitine translocase in skeletal muscles impairs utilization of fatty acids in insulin-resistant patients. Front Biosci 7 (2002) a109-a116
32. Shulman G.I. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology (Bethesda) 19 (2004) 183-190
33. Labayen I., Diez N., Parra D., Gonzalez A., and Martinez J.A. Basal and postprandial substrate oxidation rates in obese women receiving two test meals with different protein content. Clin Nutr 23 (2004) 571-578
34. Torgan C.E., Brozinick Jr. J.T., Kastello G.M., and Ivy J.L. Muscle morphological and biochemical adaptations to training in obese zucker rats. J Appl Physiol 67 (1989) 1807-1813
35. Franch J., Knudsen J., Ellis B.A., Pedersen P.K., Cooney G.J., and Jensen J. Acyl-CoA binding protein expression is fiber type-specific and elevated in muscles from the obese insulin-resistant zucker rat. Diabetes 51 (2002) 449-454
36. Goodpaster B.H., Wolfe R.R., and Kelley D.E. Effects of obesity on substrate utilization during exercise. Obes Res 10 (2002) 575-584
37. Hulver M.W., Berggren J.R., Cortright R.N., Dudek R.W., Thompson R.P., Pories W.J., et al. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284 (2003) E741-E747
38. Majer M., Popov K.M., Harris R.A., Bogardus C., and Prochazka M. Insulin downregulates pyruvate dehydrogenase kinase (PDK) MRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol Genet Metab 65 (1998) 181-186
39. Mazumder P.K., O'Neill B.T., Roberts M.W., Buchanan J., Yun U.J., Cooksey R.C., et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant Ob/Ob mouse hearts. Diabetes 53 (2004) 2366-2374
40. Wang M.Y., and Unger H.R. Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone. Am J Physiol Endocrinol Metab 288 (2005) E216-E221
41. Kelley D.E., Goodpaster B., Wing R.R., and Simoneau J.A. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277 (1999) E1130-E1141